ASD (Q.1): Which of the following stimulant is shown to have negative net benefit score (benefit minus adverse) in autism spectrum disorder? Amphetamine dexmethylphenidate methylphenidate amphetamine/ dextroamphetamine (Adderall) (Q.2): Which of the following antipsychotics is shown to have better net benefit score (benefit minus adverse) in patients with autism spectrum disorder (compared to other antipsychotics)? risperidone olanzapine quetiapine all have same net benefit score (Q.3): Which of the following statement is not correct regarding the use of psychotropic medications in patients with autism spectrum disorder (ASD)? Stimulants overall are less efficacious and cause more side effects in patients with ASD. SSRIs demonstrate less efficacy for treatment of interfering repetitive behaviors and are poorly tolerated in patients with ASD There are no FDA approved medications for autism related irritability. None of the above. Time's up Share
Responses